Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth.
Based on our preclinical findings, we are assessing the efficacy of intratumoral injection of dendritic cells (DC) transduced with an adenoviral vector expressing the secondary lymphoid chemokine (CCL21) gene (Ad-CCL21-DC) in a phase I trial in advanced non-small cell lung cancer (NSCLC). While this...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-05-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3086906?pdf=render |